KIORA PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
KIORA PHARMACEUTICALS, INC. (KPRX) had Operating Lease Right-of-Use Assets of $260.75 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07
- 2026-06-30: Operating Lease, Right-of-Use Asset $260.75K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $301.49K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $285.83K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $318.04K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $260.75K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $301.49K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $285.83K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $318.04K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $349.02K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $152.08K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $57.17K 10-K · filed 2026-03-25 |
| 2024-09-30 | $72.64K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $82.32K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $94.30K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $106.89K 10-K · filed 2025-03-25 |
| 2023-09-30 | $18.73K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $50.22K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $84.50K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $116.99K 10-K · filed 2024-03-25 |
| 2022-09-30 | $147.46K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $175.25K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $158.31K 10-Q · filed 2022-07-08 |
| 2021-12-31 | $209.41K 10-K · filed 2023-03-23 |
| 2021-09-30 | $259.22K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $308.01K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $242.73K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $83.93K 10-K/A · filed 2022-07-07 |
| 2019-06-30 | $109.51K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $97.35K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |